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Tumors of the pineal region represent about 0.4-1% of intracranial neoplasms, 
including those tumors of germ cell origin (primarily germinomas and teratomas, 
which represent about 80% of pineal malignancies), and those tumors of the pineal 
parenchyma (pineocytoma and pineoblastoma). Pineocytoma is composed of 
relatively mature cells of the pineal parenchyma, whereas pineoblastoma 
represents a more primitive form resembling medulloblastoma. The rarity of these 
tumors would account for the scarcity of cytogenetic studies performed on 
pineocytoma-pineoblastoma; only four cases have been previously reported. Griffin 
et al. analyzed two pineoblastomas occurring following hereditary retinoblastoma. 
The first sample displayed abnormalities of chromosome 1: del(1)(p31p21) and der 
t(1;?)(p36;?), whereas a 1q + and a Dq + chromosome characterized the second 
sample. Sreekantaiah et al.found a del(11)(q13.1q13.5) as the sole deviation in 
one pineoblastoma, which also displayed a cell including a del(1)(p31p36) in 
addition to the 11q -. Finally, Rainho et el. analyzed a pineocytoma characterized 
by numerical alterations (losses) involving chromosomes X, 5, 8, 11, 14, and 22, 
and structural rearrangements of chromosomes 1,3, 12, and 22, as follows: 
inv(1)(p31q44); del(3)(q11); del(12)(q22); del(22)(q11.2). 
 
As a part of a comprehensive analysis of the cytogenetic characteristics of nervous 
system tumors, we have performed chromosome studies on a sample derived from 
a pineocytoma, arising in a 42-year-old male patient. A total of 67 metaphases 
were analyzed by a direct method (25 cells) or after 7 days of in vitro growth (42 
cells), utilizing the methodology previously described in detail. Heterogeneous 
chromosomal complements, which ranged from 41 and 47 chromosomes, with a 
pseudodiploid modal number, were found. Although poor-quality chromosome 
preparations were obtained, clonal numerical deviations were observed (in at least 
seven cells) involving chromosomes Y, 10, 18, 21, and 22. Structural 
rearrangements were identified as follows: der(2)t(2;12)(q33-36;q13) (23 cells); 
del(6)(q13q16) (12 cells); del(11)(q23) (18 cells); add(12)(q24) (11 cells); mar 
(small metacentric) (19 cells). Our findings are partially in agreement with the 
cytogenetic data previously obtained on pineocytomas-pineoblastomas; no 
abnormalities of chromosome 1 were observed in our case, but we confirm the 
involvement of 11q, although in a region (q23-qter) slightly more distal than that 
deleted in the case studied by Sreekantaiah et al. Losses of chromosome 22 and a 
deletion of the distal 12q region were observed as clonal in the case reported here, 
as occurs in the tumor reported by Rainho et al. Although the cytogenetic data 
based on five samples do not allow firm conclusions to be drawn, an 
involvement of lp, as well as deletions of monosomy for chromosome 11, deletions 
of the distal 12q, and monosomy or deletion of chromosome 22, seem to be the 
chromosomal abnormalities recurrently found (in at least two samples) in 
this type of neoplasm. Of these alterations, only those affecting chromosome 22 
(determined as losses at the cytogenetic level and as loss of heterozygosity in 
molecular studies) have been consistently found in association with the 
development of other histologic subtypes of brain tumors such as meningiomas, 
neurinomas, and malignant gliomas. Whether or not genes located on  
chromosomes 1, 11, 12, and 22 play a role in tumorigenesis of 
pineocytoma/pineoblastoma awaits additional cytogenetic data on a larger series of 
this type of tumors. These studies will doubtless contribute to a more precise 
identification of the chromosomal regions non-randomly involved, providing 
clues about the genomic domains where genes participating in the development of 
these neoplasms may be located. 
 
 
